Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 64 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-upCompletedNCT00198341Not applicable
• Chemoradiotherapy in Patients With Localised Lung CancerCompletedNCT00193921Phase 2
• Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung CancerCompletedNCT00193336Phase 2
• Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung CarcinomaStatus unknownNCT00192829
• Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC ChemotherapyCompletedNCT00191841Phase 2
• Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung CancerCompletedNCT00191763Phase 2
• Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.CompletedNCT00191620Phase 2
• A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung CancerCompletedNCT00191490Phase 2
• Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung CancerCompletedNCT00191256Phase 2
• Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung CancerCompletedNCT00191230Phase 2
• Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLCCompletedNCT00191126Phase 3
• A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00190840Phase 2
• A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung CancerCompletedNCT00190710Phase 3
• Elderly NSCLC/D vs DP (JCOG0207)TerminatedNCT00190476Phase 3
• Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated AtelectasisStatus unknownNCT00184964Not applicable
• Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.CompletedNCT00181545Phase 1
• Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLCCompletedNCT00181532Phase 2
• HI-CHART:Feasibility of High-Dose Accelerated Conformal RadiotherapyCompletedNCT00181506Phase 1/2
• Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung CancerTerminatedNCT00179699Phase 1
• A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung CancerCompletedNCT00179686Phase 2
• Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00176137Phase 3
• Detection of Early Lung Cancer by Serum Protein Expression ProfilingStatus unknownNCT00175578
• MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung CancerTerminatedNCT00174369Phase 2
• PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC PatientsCompletedNCT00174356Phase 1
• Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00173888Phase 2
• Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung CancerCompletedNCT00173875Phase 2
• PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)Status unknownNCT00173524
• Phase II Study of Docetaxel Plus CDDP for NSCLC Stage IIICompletedNCT00172380Phase 2
• Study for Patients With Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00168883Phase 2
• Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung CancerCompletedNCT00167401Phase 2
• Cetuximab and Vinorelbine in Elderly Subjects With Lung CancerCompletedNCT00165334Phase 2
• A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00162318Phase 1
• Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression ProfilingTerminatedNCT00161278Phase 2
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung CancerCompletedNCT00160069Phase 2
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.CompletedNCT00160043Phase 2
• Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00154739Phase 2
• Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung CancerStatus unknownNCT00150657Phase 2
• Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.CompletedNCT00148395Phase 3
• Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung CancerCompletedNCT00139711Phase 2
• Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer PatientsCompletedNCT00137800Phase 2
• PET Imaging in Potentially Surgically Resectable Non-small Cell Lung CancersCompletedNCT00136890Phase 3
• Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)CompletedNCT00136864Phase 3
• Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)CompletedNCT00132665Phase 3
• EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given CyclophosphamideCompletedNCT00132522Phase 1
• ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00132379Phase 1
• Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung CancerCompletedNCT00129844Phase 2
• Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung CancerCompletedNCT00129012Phase 1
• Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung CancerCompletedNCT00128999Phase 1/2
• A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)TerminatedNCT00126451Phase 2
• Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00124280Phase 2
• A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck CancersStatus unknownNCT00122239
• Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to ChemotherapyCompletedNCT00120679Phase 2
• Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00118183Phase 2
• VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC FeaturesTerminatedNCT00117351Phase 2
• Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00115518Phase 2
• Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyCompletedNCT00115206Phase 4
• Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00114192Phase 2
• Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00112710Phase 3
• Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00112346Phase 2
• A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT00112060Phase 1/2
• Celecoxib Treatment for Lung CancerWithdrawnNCT00108186Phase 1
• Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.CompletedNCT00105092Phase 2
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerStatus unknownNCT00104780Phase 2
• Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00104767Phase 1
• Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung CancerCompletedNCT00103831Phase 1/2
• Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00103389Phase 2
• A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00102505Phase 1
• ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00101920Phase 2
• Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
• Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00100854Phase 2
• Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung CancerTerminatedNCT00099879Phase 2
• Non-small Cell Lung Cancer RegistryCompletedNCT00099541Phase 4
• Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNCT00098917Phase 1
• Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00098540Phase 2
• Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00098462Phase 1/2
• Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung CancerCompletedNCT00098085Phase 2
• Trial of Oral Karenitecin in Patients With Solid Tumors and Lung CancerCompletedNCT00097903Phase 1
• Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00097851Phase 2
• Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097227Phase 2
• Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097214Phase 2
• A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)CompletedNCT00095225Phase 2
• Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or MediastinumTerminatedNCT00094978Phase 1
• Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00094822
• Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous RadiotherapyTerminatedNCT00093132Phase 1/2
• Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00092924Phase 2
• Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00092001Phase 2
• A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00091663Phase 3
• Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00091156Phase 3
• Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With SurgeryCompletedNCT00091039Not applicable
• Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung CancerWithdrawnNCT00090675Phase 3
• A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00089726Phase 2
• Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung CancerCompletedNCT00089310Not applicable
• Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00088959Phase 1
• Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal CancerTerminatedNCT00088933Phase 1
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00088556Phase 1/2
• STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)CompletedNCT00088088Phase 1/2
• Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00087802Phase 3
• A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00087711Phase 3
• S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung CancerCompletedNCT00087412Phase 2
• Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical ResectionTerminatedNCT00087269Phase 2

← Carcinoma, Non-Small-Cell Lung overview